Register entry
SUNOVION PHARMACEUTICALS INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 30
- Countries
- 0
Exclusivity
Patents and exclusivities
30| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8729085*PED | LATUDAlurasidone hydrochloride | use | Nov 2026 |
| 8883794*PED | LATUDAlurasidone hydrochloride | use | Nov 2026 |
| 9907794*PED | LATUDAlurasidone hydrochloride | use | Nov 2026 |
| 9259423 | LATUDAlurasidone hydrochloride | use | May 2031 |
| 9827242 | LATUDAlurasidone hydrochloride | use | May 2031 |
| 9259423*PED | LATUDAlurasidone hydrochloride | use | Nov 2031 |
Enquiry
Common questions
- Is SUNOVION PHARMACEUTICALS INC FDA approved?
- SUNOVION PHARMACEUTICALS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.